NYSE:GEN - Genesis Healthcare Stock Price, Forecast & News

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

Genesis Healthcare Inc (NYSE:GEN) announced its quarterly earnings data on Thursday, November, 7th. The company reported $0.40 EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.09) by $0.49. The business earned $1.12 billion during the quarter, compared to the consensus estimate of $1.13 billion. View Genesis Healthcare's Earnings History.

Genesis Healthcare is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Genesis Healthcare.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Genesis Healthcare.

Media coverage about GEN stock has trended extremely negative on Friday, InfoTrie reports. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Genesis Healthcare earned a news impact score of -4.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Genesis Healthcare.

Some companies that are related to Genesis Healthcare include Orchard Therapeutics (ORTX), Kodiak Sciences (KOD), Natus Medical (NTUS), NextCure (NXTC), Fate Therapeutics (FATE), Spectrum Pharmaceuticals (SPPI), Rhythm Pharmaceuticals (RYTM), Tivity Health (TVTY), Opko Health (OPK), Knight Therapeutics (GUD), Krystal Biotech (KRYS), ZEALAND PHARMA/S (ZEAL), Karyopharm Therapeutics (KPTI), Mesa Laboratories (MLAB) and Phreesia (PHR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Genesis Healthcare investors own include Flaherty&Crumrine Prfrd Scts Incm Fd (FFC), Government Properties Income Trust (GOV), General Electric (GE), Montage Resources (MR), Advanced Micro Devices (AMD), Senior Housing Properties Trust (SNH), Hecla Mining (HL), Kinder Morgan (KMI), Rite Aid (RAD) and Athersys (ATHX).

Genesis Healthcare's stock is owned by many different of institutional and retail investors. Top institutional investors include V3 Capital Management L.P. (2.76%), Chevy Chase Trust Holdings Inc. (1.48%), State Street Corp (0.69%), Millennium Management LLC (0.55%), Virtu Financial LLC (0.03%) and Barclays PLC (0.03%). Company insiders that own Genesis Healthcare stock include David A Reis, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis Healthcare.

GEN stock was sold by a variety of institutional investors in the last quarter, including Barclays PLC. Company insiders that have sold Genesis Healthcare company stock in the last year include Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare.

GEN stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Chevy Chase Trust Holdings Inc., V3 Capital Management L.P., State Street Corp and Virtu Financial LLC. View Insider Buying and Selling for Genesis Healthcare.

Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of GEN stock can currently be purchased for approximately $1.72.

Genesis Healthcare has a market capitalization of $283.46 million and generates $4.98 billion in revenue each year. The company earns $-235,230,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. Genesis Healthcare employs 61,300 workers across the globe.View Additional Information About Genesis Healthcare.

The official website for Genesis Healthcare is http://www.genesishcc.com/.

Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]